ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 420441 | Rec_0433099 | Enterocin P |
ATRSYGNGVYCNNSKCWVNWGEAKENIAGIVISGWASGLAGMGH |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Anti-Gram+ |
Clostridium perfringens MLG4201 |
100 µg/mL | MIC |
38338877 | - |
YES |
| 420442 | Rec_0433100 | Enterocin P |
ATRSYGNGVYCNNSKCWVNWGEAKENIAGIVISGWASGLAGMGH |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Anti-Gram+ |
Clostridium perfringens MLG4206 |
>100 µg/mL | MIC |
38338877 | - |
YES |
| 420443 | Rec_0433101 | Enterocin P |
ATRSYGNGVYCNNSKCWVNWGEAKENIAGIVISGWASGLAGMGH |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Anti-Gram+ |
Clostridium perfringens MLG5719 |
>100 µg/mL | MIC |
38338877 | - |
YES |
| 420444 | Rec_0433102 | Enterocin P |
ATRSYGNGVYCNNSKCWVNWGEAKENIAGIVISGWASGLAGMGH |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Anti-Gram+ |
Clostridium perfringens MLG5806 |
>100 µg/mL | MIC |
38338877 | - |
YES |
| 420445 | Rec_0433103 | Enterocin P |
ATRSYGNGVYCNNSKCWVNWGEAKENIAGIVISGWASGLAGMGH |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Anti-Gram+ |
Clostridium perfringens MLG6907 |
>100 µg/mL | MIC |
38338877 | - |
YES |
| 420446 | Rec_0433104 | Enterocin P |
ATRSYGNGVYCNNSKCWVNWGEAKENIAGIVISGWASGLAGMGH |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Anti-Gram+ |
Clostridium perfringens MLG7009 |
>100 µg/mL | MIC |
38338877 | - |
YES |
| 420447 | Rec_0433105 | Enterocin P |
ATRSYGNGVYCNNSKCWVNWGEAKENIAGIVISGWASGLAGMGH |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Anti-Gram+ |
Clostridium perfringens MLG7307 |
1.56 µg/mL | MIC |
38338877 | - |
YES |
| 420448 | Rec_0433106 | Enterocin P |
ATRSYGNGVYCNNSKCWVNWGEAKENIAGIVISGWASGLAGMGH |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Anti-Gram+ |
Clostridium perfringens MLG7309 |
100 µg/mL | MIC |
38338877 | - |
YES |
| 420449 | Rec_0433107 | Enterocin P |
ATRSYGNGVYCNNSKCWVNWGEAKENIAGIVISGWASGLAGMGH |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Anti-Gram+ |
Clostridium perfringens MLG7814 |
>100 µg/mL | MIC |
38338877 | - |
YES |
| 420450 | Rec_0433108 | Enterocin P |
ATRSYGNGVYCNNSKCWVNWGEAKENIAGIVISGWASGLAGMGH |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Anti-Gram+ |
Listeria monocytogenes ATCC 1911 |
<0.19 µg/mL | MIC |
38338877 | - |
YES |
| 420451 | Rec_0433109 | Cherimolacyclopeptide C |
AAWIPPG |
Annona cherimola [Plant] |
Anticancer, Cytotoxic |
KB cells |
0.072 μM | IC50 (in vitro cytotoxicity assay) |
15387664 | - |
YES |
| 420452 | Rec_0433110 | YLMSR (PC-1) |
YLMSR |
Pseudosciaena crocea [Animal] |
Antioxidant, Radical scavenging |
DPPH radical |
1.35 mg/mL | EC50 (DPPH radical scavenging) |
25172761 | - |
YES |
| 420453 | Rec_0433111 | YLMSR (PC-1) |
YLMSR |
Pseudosciaena crocea [Animal] |
Antioxidant, Radical scavenging |
superoxide radical |
0.450 mg/mL | EC50 (superoxide radical scavenging) |
25172761 | - |
YES |
| 420454 | Rec_0433112 | YLMSR (PC-1) |
YLMSR |
Pseudosciaena crocea [Animal] |
Antioxidant, Radical scavenging |
ABTS radical |
0.312 mg/mL | EC50 (ABTS radical scavenging) |
25172761 | - |
YES |
| 420455 | Rec_0433113 | Caplacizumab |
EVQLVESGGGLVQPGGSLRLSCAASGRTFSYNPMGWFRQAPGKGRELVAAISRTGGSTYYPDSVEGRFTISRDNAKRMVYLQMNSLRAEDTAVYYCAAAGVRAEDGRVRTLPSEYTFWGQGTQVTVSSAAAEVQLVESGGGLVQPGGSLRLSCAASGRTFSYNPMGWFRQAPGKGRELVAAISRTGGSTYYPDSVEGRFTISRDNAKRMVYLQMNSLRAEDTAVYYCAAAGVRAEDGRVRTLPSEYTFWGQGTQVTVSS |
synthetic construct [Synthetic] |
Antithrombotic, VWF-binding, Platelet-adhesion inhibitor |
von Willebrand factor (VWF)–platelet glycoprotein Ib interaction |
- | VWF:GPIbM / VWF:RCo functional activity assay |
40915571 | - |
YES |
| 420456 | Rec_0433114 | Orexin-A |
XPLPDCCRQKTCSCRLYELLHGAGNHAAGILTL |
Homo sapiens [Animal] |
Neuropeptide, Orexin receptor agonist |
human orexin receptor OX1 |
0.22±0.06 nM | EC50 (CHO cell functional receptor assay) |
24707347 | - |
YES |
| 420457 | Rec_0433115 | Orexin-A |
XPLPDCCRQKTCSCRLYELLHGAGNHAAGILTL |
Homo sapiens [Animal] |
Neuropeptide, Orexin receptor agonist |
human orexin receptor OX2 |
1.07±0.3 nM | EC50 (CHO cell functional receptor assay) |
24707347 | - |
YES |
| 420458 | Rec_0433116 | Tryptophyllin L1 (FPWL-NH2) |
FPWL |
Litoria rubella [Animal] |
Neuropeptide, Opioid, μ-opioid receptor activity |
μ-opioid receptor |
1×10^-7 M | opioid activity assay |
21598333 | - |
YES |
| 420459 | Rec_0433117 | SEQ ID NO:15 |
KKATALVGAASLTAWVGLASAKKKK |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Escherichia coli C498 |
- | MIC assay (qualitative positive in patent Table 2) |
- | US 2004/0235745 A1 |
YES |
| 420460 | Rec_0433118 | SEQ ID NO:15 |
KKATALVGAASLTAWVGLASAKKKK |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Escherichia coli C500 |
- | MIC assay (qualitative positive in patent Table 2) |
- | US 2004/0235745 A1 |
YES |